DNA damage in leukocytes of workers occupationally exposed to arsenic in copper smelters

Environmental and Molecular Mutagenesis

Volumn 46, Issue 2, 2005, Pages 81-87

  Palus, Jadwiga ^a   Lewinska, Dobroslawa ^a   Dziubaltowska, Elzbieta ^a   Stepnik, Maciej ^a   Beck, Jens ^b   Rydzynski, Konrad ^a   Nilsson, Robert ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Arsenic; Comet assay; Human lymphocytes; Occupational exposure; Urine

Indexed keywords

ARSENIC; ARSENIC ACID; ARSENIC TRIOXIDE; CACODYLIC ACID; CARCINOGEN; COPPER; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; DRINKING WATER; METHANEARSONIC ACID;

ADULT; ARSENIC POISONING; ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; POLAND; SMELTER; SOMATIC CELL; URINALYSIS;

ADULT; AIR POLLUTANTS, OCCUPATIONAL; ARSENIC; CACODYLIC ACID; COMET ASSAY; COPPER; DATA INTERPRETATION, STATISTICAL; DNA DAMAGE; ENVIRONMENTAL MONITORING; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MINING; OCCUPATIONAL EXPOSURE; POLAND;

EID: 24944492235     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.20132     Document Type: Article

References (52)

1. Apostoli P, Bartoli D, Alessio L, Buchet JP. 1999. Biological monitoring of occupational exposure to inorganic arsenic. Occup Environ Med 56(12):825-832.
2. Barren JC, Lamb PW, Wang TC, Lee TC. 1989. Mechanism of arsenic induced cell transformation. Biol Trace Elem Res 21:421-429.
3. Basu A, Mahata J, Gupta S, Giri AK. 2001. Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat Res 488: 171-194.
4. Calderon RL, Hudgens E, Le X Ch, Schreinmachers D, Thomas DJ. 1999. Excretion of arsenic in urine as a function of exposure to arsenic in drinking water. Environ Health Perspect 107:663-667.
5. Chen CJ, Chen CW, Wu MM, Kuo TL. 1992. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 66:888-892.
6. Chen CJ, Hsu LI, Tseng CH, Hsueh YM, Chiou HY. 1999. Emerging epidemics of arseniasis in Asia. In: Chappell WR, Abernathy CO, Calderon RL, editors. Arsenic exposure and health effects. 1st edition. Amsterdam, Lausanne, New York, Oxford, Shannon, Singapore, Tokyo: Elsevier Science, pp 113-121.
7. Chen W, Martindale JL, Holbrook NJ, Liu YY. 1998. Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and she. Mol Cell Biol 18(9):5178-5188.
8. Christman JK, Sheiknejad G, Dizik M, Abileah S, Wainfan E. 1993. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary deficiency. Carcinogenesis 14(4):551-557.
9. Cohen SM, Arnold LL, St. John MK, Cano M. 1999. Evaluation of cell proliferative activity in the rat urinary bladder after feeding high doses of cacodilic acid. In: Chappell WR, Abernathy CO, Calderon RL, editors. Arsenic exposure and health effects. 1st edition. Amsterdam, Lausanne, New York, Oxford, Shannon, Singapore, Tokyo: Elsevier Science, pp 253-262.
10. de la Rosa ME, Magnusson J, Ramel C, Nilsson R. 1994. Modulating influence of inorganic arsenic on the recombinogenic and mutagenic action of ionizing radiation and alkylating agents in Drosophila melanogaster. Mutat Res 318:65-71.
11. Dizik M, Christman JK, Wainfan E. 1991. Alteration in expression and methylation of specific genes in livers of rats fed cancer promoting methyl-deficient diet. Carcinogenesis 12(7):1307-1312.
12. Dulout FN, Grillo CA, Seoane AI, Maderna CR, Nilsson R, Vahter M, Darroudi F, Natarajan AT. 1996. Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from northwestern Argentina exposed to arsenic in drinking water. Mutat Res 370:151-158.
13. Gebel TW. 1998. Suppression of arsenic-induced chromosome mutagenicity by antimony. Mutat Res 412:213-218.
14. Germolec DR, Spalding J, Boorman GA, Wilmer JL, Yoshida T, Simenova P, Bruccoleri A, Kayama F, Gaido K, Tennant R, Burleson F, Dong W, Lang RW, Luster MI. 1997. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat Res 386:209-218.
15. Gomez-Ariza JL, Sanchez-Rodas D, Beltran R, Corns W, Stockwel P. 1998. Evaluation of atomic fluorescence spectrometry as a sensitive detection technique for arsenic speciation. Appl Organomet Chem 12:439-447.
16. Gosebatt ME, Vega L, Salazar AM, Montera R, Guzman P, Blas J. 1997. Cytogenetic effects in human exposure to arsenic. Mutat Res 386(3):219-228.
17. Hakala E, Pyy L. 1995. Assessment of exposure to inorganic arsenic by determining the arsenic species excreted in urine. Toxicol Lett 77:249-258.
18. Hartmann A, Speit G. 1994. Comparative investigations of the genotoxic effects of metals in the single cell gel (SCG) test. Environ Mol Mutagen 23:299-305.
19. Hartwig A, Groblinghoff UD, Beyersmann D, Natarajan AT, Filon R, Mullenders LH. 1997. Interaction of arsenic (III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis 18:399-405.
20. Hei TK, Liu SX, Waldren C. 1998. Mutagenicity of arsenic in mammalian cells; role of reactive oxygen species. Proc Natl Acad Sci USA 95:8103-8107.
21. Hopenhayn-Rich C, Hertz-Picciotto I, Browning S, Ferreccio C, Peralta C. 1999. Reproductive and developmental effects associated with chronic arsenic exposure. In: Chappell WR, Abernathy CO. Calderon RL, editors. Arsenic exposure and health effects. 1st edition. Amsterdam, Lausanne, New York, Oxford, Shannon, Singapore, Tokyo: Elsevier Science, pp 151-164.
22. Hsu YH, Li SY, Chiou HY, Yeh PM, Liou JC, Hsueh YM, Chang SH, Chen CJ. 1997. Spontaneous and induced sister chromatid exchanges and delayed cell proliferation in peripheral lymphocytes of Bowen's disease patients and matched controls of arseniasis-hyperendemic villages in Taiwan. Mutat Res 386:241-251.
23. International Agency for Research on Cancer (IARC). 1980. Monographs on the Evaluation of the carcinogenic risks to humans-some metals and metallic compounds. Lyon: WHO, vol. 23, pp 39-141.
24. International Agency for Research on Cancer (IARC). 1987. Monographs on the evaluation of the carcinogenic risks to humans-arsenic. Overall evaluation of carcinogenicity: an updating of IARC monographs. Lyon, France: IARC, suppl. 7, pp 100-106.
25. International Agency for Research on Cancer (IARC). 2002. Monographs on the evaluation of the carcinogenic risks to humans-some drinking-water Disinfectants and contaminants, including arsenic. Lyon: WHO, vol. 84.
26. Lee-Chen SF, Yu CT, Jan KY. 1992. Effects of arsenite on the DNA repair of UV-irradiated Chinese hamster ovary cells. Mutagen 7:51-55.
27. Li D, Morimoto K, Takeshita T, Lu Y. 2001. Formamidopyrimidine-DNA glycosylase enhances arsenic-induced DNA strand breaks in PHA-stimulated and instimulated human lymphoctes. Environ Health Perspect 109(5):523-526.
28. Li JH, Rossman TG. 1989. Mechanism of comutagenesis of sodium arsenite with N-methyl-N-nitrosourea. Biol Trace Element Res 21:373-381.
29. Liu F, Jan KY. 2000. DNA damage in arsenite and cadmium-treated bovine aortic endothelial cells. Free Radic Biol Med 28:55-63.
30. Lynn S, Gurr JR, Lai HT, Jan KY. 2000. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ Res 86:514-519.
31. Maki-Paakkanen J, Kurttio P, Paldy A, Pekkanen J. 1998. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ Mol Mutagen 32:301-313.
32. Mazumder DNG, De BK, Santra A, Dasgupta J, Ghosh N, Roy BK. 1999. Chronic arsenic toxicity: epidemiology, natural history and treatment. In: Chappell WR, Abernathy CO, Calderon RL, editors. Arsenic exposure and health effects. 1st edition. Amsterdam, Lausanne, New York, Oxford, Shannon, Singapore, Tokyo: Elsevier Science, pp 335-347.
33. Mc Kelvey-Martin VJ, Green MHL, Schmezer P, Pool-Zobel BL, De Meo MP, Collins A. 1993. The single cell gel electrophoresis assay (comet assay): a European review. Mutat Res 288:47-63.
34. Morales KH, Ryan L, Kuo TL, Wu MM, Chen CJ. 2000. Risk of internal cancers from arsenic in drinking water. Environ Health Perspect 108(7):655-661.
35. Nilsson R, Jha AN, Zaprianov Z, Natarajan AT. 1993. Chromosomal aberration in humans exposed to arsenic in the Srednogorie areas Bulgaria. Fresenius Environ Bull 2:59-64.
36. Nordenson I, Beckman L. 1991. Is the genotoxic effect of arsenic mediated by oxygen free radicals? Hum Hered 41:71-73.
37. Okoji RS, Leininger J, Froines JR. 1999. Subchronic toxicity study of sodium arsenite in methyl-deficient male C57BL/6 mice. In: Chappell WR, Abernathy CO, Calderon RL, editors. Arsenic exposure and health effects. 1st editon. Amsterdam, Lausanne, New York, Oxford, Shannon, Singapore, Tokyo: Elsevier Science, pp 225-232.
38. Ostrosky-Wegman P, Gonsebatt ME, Montera R, Vega L, Barba H, Espinosa J. 1991. Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico. Mutat Res 250:477-482.
39. Rossman TG. 1981. Enhancement of UV-mutagenesis by low concentrations of arsenite in E. coli. Mutat Res 91:207-211.
40. Simenova PP, Luster MI. 2000. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms? J Environ Pathol Toxicol Oncol 19:281-286.
41. Simenova PP, Wang S, Toriuma W, Kommineni V, Matheson J, Unimye N, Kayama F, Harki D, Ding M, Vallyathan V, Luster MI. 2000. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res 60:3445-3453.
42. Singh NP, McCoy MT, Tice RR, Schneider EL. 1988. A simple technique for quantification of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191.
43. Smith AH, Arroyo AP, Mazumder DNG, Kosnett MJ, Hernandez AL, Beeris M. 2000. Arsenic-induced skin lesions among Atacameno people in Northern Chile despite good nutrition and centuries of exposure. Environ Health Perspect 108(7):617-620.
44. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HN, Herz-Piccioto I, Duggan H. 1992. Cancer risk from arsenic in drinking water. Environ Health Perspect 97:259-267.
45. Snyder R, Davis G, Lachman P. 1989. Inhibition by metals of X-ray and ultraviolet-induced DNA repair in human cells. Biol Trace Elem Res 21:389-398.
46. StatSoft Poland. 1997. STATISTICA PL for Windows, Vol. I: General Conventions and Statistics 1. Polish edition. Cracow, Poland.
47. Sun GF, Dai GJ, Li FJ, Yamauchi H, Yoshida T, Aikawa H. 1999. The present situation of chronic arsenism and research in China. In: Chappell WR, Abernathy CO, Calderon RL, editors. Arsenic exposure and health effects, 1st edition. Amsterdam, Lausanne, New York, Oxford, Shannon, Singapore, Tokyo: Elsevier Science, pp 123-125.
48. Tinwell H, Stephens SC, Ashby J. 1991. Arsenic as the probable active species in the human carcinogenicity of arsenic: mouse micronucleus assays on Na and K arsenite, orpiment, and Fowler's solution. Environ Health Perspect 95:205-210.
49. Tsai SM, Wang TS, Ko YC. 1999. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch Environ Health 54(3):186-193.
50. Welch AH, Helsel DR, Focazio MJ, Watkins SA. 1999. Arsenic in ground water supplies of the United States. In: Chappell WR, Abernathy CO, Calderon RL, editors. Arsenic exposure and health effects. 1st edition. Amsterdam, Lausanne, New York, Oxford, Shannon, Singapore, Tokyo: Elsevier Science, pp 9-17.
51. Zhao CQ, Young MR, Diwan BA, Coogan TP. 1997. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci USA 94:10907-10912.
52. Zhu XH, Shen YL, Jing YK, Cai X, Jia PM, Huang Y. 1999. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst 91:772-778.